Through its enzymatic function, DPP4 regulates insulin secretion and serves as a key therapeutic target in type 2 diabetes mellitus, where its inhibition enhances GLP−1 activity to promote glycemic control.7 The gene discussed is DPP4; the disease is type 2 diabetes mellitus.